"Cell free therapy for organ repair" trang 1 - tải miễn phí từ tailieunhanh
Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: A single-institute experience

Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: A single-institute experience
10    19    1
Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites

Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
10    15    1
A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy

A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy
11    88    1
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: A retrospective analysis

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: A retrospective analysis
13    81    0
Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: A single center retrospective analysis

Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: A single center retrospective analysis
10    35    1
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma

Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma
8    45    1
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic nonsmall cell lung cancer TRAP OLIGO study (WJOG11118L)

Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic nonsmall cell lung cancer TRAP OLIGO study (WJOG11118L)
6    38    1
Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy

Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy
11    35    1
Development of a vitrification method for preserving human myoblast cell sheets for myocardial regeneration therapy

Development of a vitrification method for preserving human myoblast cell sheets for myocardial regeneration therapy
12    58    0
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry
8    57    1
Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: A retrospective observational study with use of a national database in Japan

Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: A retrospective observational study with use of a national database in Japan
6    67    1
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: A multicenter retrospective study

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: A multicenter retrospective study
10    15    1
Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed

Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed
8    29    1
AMENDMENTS TO RULE TO PREVENT DECEPTIVE MARKETING OF CREDIT REPORTS AND TO ENSURE ACCESS TO FREE ANNUAL FILE DISCLOSURES

AMENDMENTS TO RULE TO PREVENT DECEPTIVE MARKETING OF CREDIT REPORTS AND TO ENSURE ACCESS TO FREE ANNUAL FILE DISCLOSURES
51    84    0
Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients

Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
9    56    1
Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: A retrospective study

Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: A retrospective study
6    1    1
Ebook Adult stem cells: Methods and protocols

Ebook Adult stem cells: Methods and protocols
320    2    1